Jin-Zhuang Liao (Jinzhuang Liao)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Mesenchymal Stem Cells

Top Venues

The American journal of Chinese medicine

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Fu He, Yi-Ping Liu, Jin-Zhuang Liao, Yu Gan, Xiaoying Li, Rui-Rui Wang, Fang Wang, Jun Zhou, Li Zhou
Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer. The American journal of Chinese medicine 52 (3) (2024)
Yi-Fu He, Yi-Ping Liu, Jin-Zhuang Liao, Yu Gan, Xiaoying Li, Rui-Rui Wang, Fang Wang, Jun Zhou, Li Zhou
Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer. The American journal of Chinese medicine 52 (3) (2024)
Yi-Fu He, Yi-Ping Liu, Jin-Zhuang Liao, Yu Gan, Xiaoying Li, Rui-Rui Wang, Fang Wang, Jun Zhou, Li Zhou
Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer. The American journal of Chinese medicine (2024)
Li Xie, Jin-Zhuang Liao, Wenbin Liu, Ruirui Wang, Xiaoying Li, Wei Li, Zhongsu Zhou
Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis. Cell death discovery 9 (1) (2023)
Zhongsu Zhou, Shuangze Han, Jin-Zhuang Liao, Rui-Rui Wang, Xinfang Yu, Ming Li
Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin. The American journal of Chinese medicine (2023)